Femasys announced that it has completed the Stage 2 European Union (EU) Medical Device Regulation onsite audit resulting in zero nonconformances and no findings. This is the final audit phase in the MDR designation process that was conducted by TUV SUD America Inc., a recognized Auditing Organization and Notified Body. Successful completion of both Stage 1 and Stage 2 MDR audits confirms Femasys is compliant in all areas of MDR and may progress to issuance of the MDR certification, allowing for Femasys’ products to secure CE Marking.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FEMY:
- Femasys Inc. EU MDR Final Audit Successfully Completed
- Femasys to showcase FemBloc, other products at AAGL meeting
- Femasys Inc. Regains Compliance with Nasdaq Listing Requirements
- Femasys regains compliance with Nasdaq listing requirements
- Femasys Inc. to Showcase FemaSeed at the Annual Meeting of the American Society of Reproductive Medicine